Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Improving SARS-CoV-2 cumulative incidence estimation through mixture modelling of antibody levels

View ORCID ProfileC. Bottomley, M. Otiende, S. Uyoga, K. Gallagher, E.W. Kagucia, A.O. Etyang, D. Mugo, J. Gitonga, H. Karanja, J. Nyagwange, I.M.O. Adetifa, A. Agweyu, D.J. Nokes, G.M. Warimwe, J.A.G. Scott
doi: https://doi.org/10.1101/2021.04.09.21254250
C. Bottomley
1International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK
2Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C. Bottomley
  • For correspondence: christian.bottomley@lshtm.ac.uk
M. Otiende
2Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
3KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Uyoga
3KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Gallagher
2Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
3KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E.W. Kagucia
3KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.O. Etyang
3KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Mugo
3KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Gitonga
3KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Karanja
3KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Nyagwange
3KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I.M.O. Adetifa
2Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
3KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Agweyu
3KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
4Nuffield Department of Medicine, Oxford University, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D.J. Nokes
3KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
5School of Life Sciences, University of Warwick, Coventry, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G.M. Warimwe
3KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
4Nuffield Department of Medicine, Oxford University, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.A.G. Scott
2Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
3KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
4Nuffield Department of Medicine, Oxford University, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

As countries decide on vaccination strategies and how to ease movement restrictions, estimates of cumulative incidence of SARS-CoV-2 infection are essential in quantifying the extent to which populations remain susceptible to COVID-19. Cumulative incidence is usually estimated from seroprevalence data, where seropositives are defined by an arbitrary threshold antibody level, and adjusted for sensitivity and specificity at that threshold. This does not account for antibody waning nor for lower antibody levels in asymptomatic or mildly symptomatic cases. Mixture modelling can estimate cumulative incidence from antibody-level distributions without requiring adjustment for sensitivity and specificity. To illustrate the bias in standard threshold-based seroprevalence estimates, we compared both approaches using data from several Kenyan serosurveys. Compared to the mixture model estimate, threshold analysis underestimated cumulative incidence by 31% (IQR: 11 to 41) on average. Until more discriminating assays are available, mixture modelling offers an approach to reduce bias in estimates of cumulative incidence.

One-Sentence Summary Mixture models reduce biases inherent in the standard threshold-based analysis of SARS-CoV-2 serological data.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement, which is also part of the EDCTP2 programme supported by the European Union; grant reference: MR/R010161/1 (CB).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The component studies were approved by Kenya Medical Research Institute Scientific and Ethics Review Unit (Protocol SSC 3426 for blood donors and Protocol SSC 4085 for health care workers, antenatal care attendees and truck drivers). Further ethical approval for the study of antenatal care attendees was obtained from the Kenyatta National Hospital University of Nairobi Ethics Review Committee (Protocol P327/06/2020) and the Kilifi County health management rapid response team.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data are available on request from the corresponding author

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted April 13, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Improving SARS-CoV-2 cumulative incidence estimation through mixture modelling of antibody levels
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Improving SARS-CoV-2 cumulative incidence estimation through mixture modelling of antibody levels
C. Bottomley, M. Otiende, S. Uyoga, K. Gallagher, E.W. Kagucia, A.O. Etyang, D. Mugo, J. Gitonga, H. Karanja, J. Nyagwange, I.M.O. Adetifa, A. Agweyu, D.J. Nokes, G.M. Warimwe, J.A.G. Scott
medRxiv 2021.04.09.21254250; doi: https://doi.org/10.1101/2021.04.09.21254250
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Improving SARS-CoV-2 cumulative incidence estimation through mixture modelling of antibody levels
C. Bottomley, M. Otiende, S. Uyoga, K. Gallagher, E.W. Kagucia, A.O. Etyang, D. Mugo, J. Gitonga, H. Karanja, J. Nyagwange, I.M.O. Adetifa, A. Agweyu, D.J. Nokes, G.M. Warimwe, J.A.G. Scott
medRxiv 2021.04.09.21254250; doi: https://doi.org/10.1101/2021.04.09.21254250

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (214)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1090)
  • Dentistry and Oral Medicine (194)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (497)
  • Epidemiology (9746)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2298)
  • Geriatric Medicine (221)
  • Health Economics (461)
  • Health Informatics (1548)
  • Health Policy (729)
  • Health Systems and Quality Improvement (600)
  • Hematology (236)
  • HIV/AIDS (500)
  • Infectious Diseases (except HIV/AIDS) (11618)
  • Intensive Care and Critical Care Medicine (615)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2136)
  • Nursing (133)
  • Nutrition (332)
  • Obstetrics and Gynecology (424)
  • Occupational and Environmental Health (516)
  • Oncology (1171)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (144)
  • Palliative Medicine (50)
  • Pathology (308)
  • Pediatrics (692)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2168)
  • Public and Global Health (4640)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (450)
  • Respiratory Medicine (621)
  • Rheumatology (273)
  • Sexual and Reproductive Health (224)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (42)
  • Transplantation (120)
  • Urology (94)